#26 of India's imports · #1 of pharma imports · Intermediates & KSMs
6-APA (penicillin intermediate): imports into India
Tariff line 29411050 · CAS 551-16-6
Imports 2025-26
13,034 t
+18.7% vs 2024-25
Import bill (CIF, before duty)
₹3,026 cr
Volume growth, 2020-21 to 2025-26
+12.3% a year
Rising
Net imports 2025-26
13,033 t
Exports 1 t
Import volume by financial year
RisingShow as table
| Year | Imports | Import bill |
|---|---|---|
| 2020-21 | 7,292 t | ₹1,253 cr |
| 2021-22 | 6,759 t | ₹1,551 cr |
| 2022-23 | 8,448 t | ₹2,848 cr |
| 2023-24 | 9,722 t | ₹3,490 cr |
| 2024-25 | 10,982 t | ₹3,594 cr |
| 2025-26 | 13,034 t | ₹3,026 cr |
Where it comes from (2025-26)
Share of the import bill
- China83.2%
- Germany6.7%
- Austria6.2%
What's changing
- Aurobindo Pharma commissioned a 3,600 t/yr 6-APA plant (Qule Pharma) and a 15,000 t/yr Penicillin-G plant (Lyfius Pharma) in the Kakinada SEZ, Andhra Pradesh.Indian Pharma Post, 2 Apr 2024
- DGTR opened an anti-dumping investigation into 6-APA from China and the EU on 25 September 2026, on an application by Qule Pharma, covering April 2025 to March 2026 (case AD/OI/059/2026).Corpseed (DGTR notification), 25 Sept 2026
Reported facts with their source. Not a forecast.
Buy or supply 6-apa (penicillin intermediate) in India
Source: Export Import Data Bank, Department of Commerce (DGCI&S data), as published on 10 Nov 2026. The import bill is the total declared value, not a price per kg. How to read these figures.